Paritosh Garg: From Replacing Platelets to Stimulating Platelet Production
Paritosh Garg, Associate Consultant at Fortis Memorial Research Institute, India, shared a post on LinkedIn about a recent article by Raoel Maan et al., published in Drugs, adding:
“Thrombocytopenia in chronic liver disease is not just a platelet-count problem.
It influences procedural planning, antiviral therapy, transfusion decisions, and thrombotic risk assessment.
This review highlights an important shift in supportive care:
From replacing platelets to stimulating platelet production.
Thrombopoietin receptor agonists opened a new therapeutic space, but the key message remains clinical judgment.
In CLD, the question is not only:
‘Can we increase the platelet count?’
It is also:
‘At what thrombotic cost, and in which patient?’
A practical reminder that supportive care in hematology is never ‘supportive only’ — it often determines whether definitive care can safely proceed.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI